The Dementia Discovery Fund is a close collaboration between charity, industry and the government, to provide much-needed investment in innovative dementia research.
The fund works collaboratively with universities, academic institutes and the biotechnology and pharmaceutical industry internationally to identify novel dementia research projects and nurture these through the pre-clinical phase, enabling further development in clinical trials.
Its priorities are to explore and develop novel hypotheses in dementia research and to increase global interest and industry confidence in the value of dementia research.
For early-stage programmes, the fund has mechanisms in place to fund up to $1m for hypothesis testing with the aim of company spin-out on achievement of agreed milestones.
For companies closer to the clinic, the fund will invest or co-invest larger amounts in order to progress through candidate selection and early clinical trials.
The DDF is keen to hear from scientists, researchers and companies developing novel therapies for dementia, who are in need of funding and help.